Evidence map›Paper›PMID 41709253›Full record

Trial reportTrials2026

Working with underrepresented groups: lessons from the SCHEMA trial.

Paula Foscarini-Craggs, Arman Iranpour, Katie Aafjes-van Doorn, Matthew Franklin, Toni Leigh Harrison, Iain McKinnon, Rachel McNamara, Elizabeth Randell, Sophie Rose, Jennifer Condie and 3 more

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Trials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Paula Foscarini-CraggsCentre for Trials Research, Cardiff University, Neuadd Meirionnydd, Heath Park, Cardiff, Wales, CF14 4YS, UK. Foscarini-CraggsP@Cardiff.ac.uk.ORCID http://orcid.org/0000-0001-9511-696X
Arman IranpourFaculty of Medical Sciences, Newcastle University Population Health Sciences Institute, Baddiley-Clark Building, Richardson Road, Newcastle Upon Tyne, England, NE2 4AX, UK.
Katie Aafjes-van DoornNew York University Shanghai, West Yangsi Rd, Pudong Xin Qu 567, Shanghai, 200124, China.
Matthew FranklinSheffield Centre for Health and Related Research (SCHARR), School of Medicine and Population Health, The University of Sheffield, Regent Court, 30 Regent Street, Sheffield, S1 4DA, England, UK.
Toni Leigh HarrisonFaculty of Medical Sciences, Newcastle University Population Health Sciences Institute, Baddiley-Clark Building, Richardson Road, Newcastle Upon Tyne, England, NE2 4AX, UK.
Iain McKinnonFaculty of Medical Sciences, Newcastle University Population Health Sciences Institute, Baddiley-Clark Building, Richardson Road, Newcastle Upon Tyne, England, NE2 4AX, UK.
Rachel McNamaraCentre for Trials Research, Cardiff University, Neuadd Meirionnydd, Heath Park, Cardiff, Wales, CF14 4YS, UK.
Elizabeth RandellCentre for Trials Research, Cardiff University, Neuadd Meirionnydd, Heath Park, Cardiff, Wales, CF14 4YS, UK.
Sophie RoseCentre for Trials Research, Cardiff University, Neuadd Meirionnydd, Heath Park, Cardiff, Wales, CF14 4YS, UK.
Jennifer CondieCentre for Trials Research, Cardiff University, Neuadd Meirionnydd, Heath Park, Cardiff, Wales, CF14 4YS, UK.
Ania ZubalaCentre for Brain Sciences, Royal Edinburgh Hospital, The University of Edinburgh, Kennedy Tower, Morningside Place, Edinburgh, EH10 5HF, UK.
Muhammad RiazCentre for Trials Research, Cardiff University, Neuadd Meirionnydd, Heath Park, Cardiff, Wales, CF14 4YS, UK.
Simon HackettFaculty of Medical Sciences, Newcastle University Population Health Sciences Institute, Baddiley-Clark Building, Richardson Road, Newcastle Upon Tyne, England, NE2 4AX, UK.

Funding

Health Education England NIHR301264National Institute for Health and Care Research NIHR301264
6 · The paper itself

Abstract

There is a growing focus on ensuring research is accessible and inclusive to individuals traditionally not represented. To be truly inclusive, the broader context needs to be explored, as barriers might not only be linked to population characteristics but also to the complexity of their environment, and limited research opportunity within certain healthcare professions. The SCHEMA trial is a randomised controlled trial evaluating whether interpersonal art psychotherapy is effective at reducing aggressive behaviour in individuals with learning disability or borderline intellectual function in secure care. The trial illustrates the challenges and solutions to conducting research in secure care settings, a challenging environment, with an underrepresented patient population and healthcare professionals unfamiliar with conducting research. To better understand the challenges, a survey was circulated to understand site staff's general experience with research and their specific experiences of the SCHEMA trial. Difficulty of balancing research with other responsibilities and a fear of making a mistake were the most common barriers. The top two facilitators were working with collaborators and the presence of clear guidelines and protocols. Site setup was identified as the most challenging stage of the trial, while follow-up data collection was identified as the least challenging. In response to these challenges, the central trial team worked closely with site staff to provide tailored support to address the unique needs of the healthcare professionals and participant population.

Indexed as

AggressionIntellectual DisabilityLearning DisabilitiesMinority GroupsPatient SelectionPersons with Intellectual DisabilitiesPsychotherapyAttitude of Health PersonnelCooperative BehaviorDiversity, Equity, InclusionHumansResearch DesignResearch PersonnelResearch SubjectsForensic researchIntellectual disability researchTrial methodologyUnderrepresented groups

Identifiers

PMID41709253
PMCPMC12918015

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.